国际肿瘤学杂志 ›› 2023, Vol. 50 ›› Issue (1): 22-27.doi: 10.3760/cma.j.cn371439-20220816-00004

• 综述 • 上一篇    下一篇

国产纳米炭混悬液在恶性肿瘤前哨淋巴结活检中的应用进展

王熠昕1, 曹蒙2, 王焱1()   

  1. 1中国医学科学院北京协和医学院皮肤病医院皮肤外科,南京 210042
    2中国医学科学院北京协和医学院皮肤病医院激光科,南京 210042
  • 收稿日期:2022-08-16 修回日期:2022-11-01 出版日期:2023-01-08 发布日期:2023-03-16
  • 通讯作者: 王焱 E-mail:drwangyan@163.com
  • 基金资助:
    国家自然科学基金(81872216)

Application progress of domestic carbon nanoparticles suspension in sentinel lymph node biopsy for malignant tumors

Wang Yixin1, Cao Meng2, Wang Yan1()   

  1. 1Department of Dermatological Surgery, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Science, Peking Union Medical College, Nanjing 210042, China
    2Department of Cosmetic Laser Surgery, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Science, Peking Union Medical College, Nanjing 210042, China
  • Received:2022-08-16 Revised:2022-11-01 Online:2023-01-08 Published:2023-03-16
  • Contact: Wang Yan E-mail:drwangyan@163.com
  • Supported by:
    National Natural Science Foundation of China(81872216)

摘要:

前哨淋巴结(SLN)是原发肿瘤淋巴结转移必经的首站淋巴结,各类示踪剂是目前SLN领域的研究热点。国产纳米炭混悬液(CNP)作为第三代特异性淋巴示踪剂,具有良好的淋巴系统趋向性,能在短时间内对淋巴结进行染色且不进入血液循环,在各类恶性肿瘤中得到了广泛应用。虽然仍有不少因素会影响到CNP示踪的有效性,但与其余种类示踪剂相比具有安全高效、无放射性、操作简便等优势,有望成为识别恶性肿瘤SLN转移的有力手段。

关键词: 肿瘤, 淋巴结, 纳米粒子

Abstract:

Sentinel lymph nodes (SLNs) are the first lymph nodes to undergo lymph node metastasis from primary tumors, and various tracers are currently being researched in the field of SLNs. Domestic carbon nanoparticles suspension (CNP) has a good lymphatic system tropism, can indeed stain lymph nodes in a short time without entering the blood circulation, and has been widely used in various malignant tumors as a third generation specific lymphatic tracer. Although there are still many factors that affect the effectiveness of CNP tracer, CNP has the advantages of safety, high efficiency, non-radioactivity and easy operation compared with other kinds of tracers, and is expected to be a powerful means to identify SLNs metastasis of malignant tumors.

Key words: Neoplasms, Lymph node, Nanoparticles